The ability to identify heart disease, image brain activity, detect and treat cancer and do many other things have made medical isotopes a key tool in the modern physician’s toolkit.

After decades of relatively stable growth of a slowly evolving product line, there have recently been some major breakthroughs, notably in the use of lutetium-177, that have challenged the supply chain. In parallel, existing machines for the essential irradiation stage of the production of some isotopes have been shutting down as they reach the end of their useful life creating additional production issues.

And there are new challenges ahead as yet more therapies, based on alpha emitters such as actinium-225, show promise.

Read here about what we are doing to support the expansion of this critical aspect of modern healthcare.

Why Us?

  • Comprehensive Capabilities

    Licensed facilities, subject matter experts and a customer focused approach to providing services enable you to get on with the business of running your plant safely, compliantly, and efficiently

  • Ground-breaking Power Reactor Production

    Working with Framatome in our Isogen joint venture and with power reactor operators, Bruce Power, we have led the world in developing technologies that enable power reactors to be used to produce short-lived medical isotopes.